Fernando Souza-Fonseca-Guimaraes Selected Research

Fernando Souza-Fonseca-Guimaraes Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 08/2013
10	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2014
8	Infections 01/2022 - 06/2012
7	Melanoma (Melanoma, Malignant) 01/2021 - 08/2014
6	Inflammation (Inflammations) 01/2022 - 08/2013
6	Sepsis (Septicemia) 03/2017 - 03/2012
3	Malaria 01/2018 - 11/2016
2	Human Influenza (Influenza) 01/2022 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 10/2021 - 01/2019
2	Arthritis (Polyarthritis) 01/2020 - 01/2020
2	Lymphoma (Lymphomas) 06/2017 - 07/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 07/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 05/2015 - 08/2014
1	Communicable Diseases (Infectious Diseases) 01/2022
1	COVID-19 01/2022
1	Persistent Infection 10/2021
1	Liver Neoplasms (Liver Cancer) 08/2021
1	Hepatocellular Carcinoma (Hepatoma) 08/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Multiple Sclerosis 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Colitis 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Carcinoma (Carcinomatosis) 06/2017
1	Leukemia 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Opportunistic Infections (Opportunistic Infection) 01/2017
1	Hypersensitivity (Allergy) 01/2016

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2020 - 03/2012
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 04/2013
4	InterferonsIBA 01/2022 - 10/2012
4	AntigensIBA 10/2021 - 01/2020
4	Interleukin-15 (Interleukin 15)IBA 01/2020 - 01/2017
3	AntibodiesIBA 01/2022 - 11/2016
2	Interferon Type IIBA 01/2022 - 11/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2021 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 06/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2017
2	LigandsIBA 06/2017 - 01/2017
2	CarcinogensIBA 06/2017 - 05/2015
2	Interferon-gamma (Interferon, gamma)IBA 03/2017 - 10/2012
1	ParaffinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Small Cytoplasmic RNAIBA 08/2021
1	Chimeric Antigen ReceptorsIBA 10/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 08/2020
1	DisintegrinsIBA 01/2020
1	cytokine inducible SH2-containing proteinIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	AntiemeticsIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	EnzymesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	PlatinumIBA 01/2020
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	FollistatinIBA 01/2019
1	OvalbuminIBA 01/2019
1	activin AIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Granzymes (Granzyme)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2018
1	Butyrates (Butyrate)IBA 01/2018
1	Antiparasitic Agents (Antiparasitics)IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	InflammasomesIBA 01/2018
1	heparanaseIBA 06/2017
1	MethylcholanthreneIBA 06/2017
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2017
1	Immunoglobulin M (IgM)IBA 11/2016
1	Immunoglobulin G (IgG)IBA 11/2016
1	Fc Receptors (Fc Receptor)IBA 07/2016
1	Alanine Transaminase (SGPT)IBA 07/2016
1	Rituximab (Mabthera)FDA Link 07/2016
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 05/2015

Therapy/Procedure

14	Immunotherapy 07/2022 - 01/2016
12	Therapeutics 07/2022 - 08/2013
2	Stem Cell Transplantation 01/2021 - 01/2016
2	Radiotherapy 01/2021 - 01/2018
2	Ligation 05/2015 - 03/2014
1	Adjuvant Chemotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017
1	Punctures 05/2015
1	Homologous Transplantation 08/2014